Our previous research has demonstrated that ALKBH5 promoted stem cell phenotype and myeloma tumorigenicity through demethylating the SAV1 mRNA of the HIPPO pathway, emphasizing the demethylation activity of ALKBH5 in MM (3). Here, ALKBH5 is linked to Miyoshi myopathy.